|
|
||||||||
The Journal of Immunology, Vol 154, Issue 12 6219-6226, Copyright © 1995 by American Association of Immunologists
ARTICLES |
Y Ando, W Wajjwalku, N Niimi, K Hiromatsu, T Morishima and Y Yoshikai
Laboratory of Host Defense and Germfree Life, Nagoya University School of Medicine, Japan.
We found that milk from II TES mice contained two species of exogenous mouse mammary tumor viruses (MMTV). Sequence analysis of the open reading frame (ORF) in the MMTV 3' long terminal repeat indicated that the two MMTV, MMTV (II TES2) and MMTV (II TES14), encode superantigens specific for V beta 2+ T cells and V beta 14+ T cells, respectively. In an experiment of subcutaneous injection of II TES milk, both T cells bearing TCR V beta 2 and V beta 14 proliferated vigorously in the draining lymph node from BALB/c mice (H-2d I-E+), whereas only V beta 14+ T cells showed significant proliferation in C57BL/6 mouse (B6 H-2b I-E-) lymph nodes. These findings indicated that the superantigen encoded by MMTV (II TES2) required MHC class II I-E molecules exclusively for Ag presentation, but MMTV (II TES14) stimulated V beta 14+ T cells even in the absence of I-E molecules. Semiquantitative analysis of MMTV proviruses using PCR revealed that B6 mice were not infected with MMTV (II TES2) by injection of this MMTV alone. However, injection of II TES milk containing both MMTV (II TES14) and MMTV (II TES2) induced infection of B6 mice with MMTV (II TES2) besides MMTV (II TES14), in spite of no expansion of V beta 2+ T cells in this mouse strain. These results suggested that I-E-negative mice were concomitantly infected with MMTV (II TES2) with the help of I-E independent T cell activation mediated by MMTV (II TES14).
This article has been cited by other articles:
![]() |
Y. Pobezinskaya, A. V. Chervonsky, and T. V. Golovkina Initial Stages of Mammary Tumor Virus Infection Are Superantigen Independent J. Immunol., May 1, 2004; 172(9): 5582 - 5587. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Umemura, W. Wajjwalku, N. Upragarin, T. Liu, H. Nishimura, T. Matsuguchi, Y. Nishiyama, G. M. Wilson, and Y. Yoshikai Expression of Mouse Mammary Tumor Virus Superantigen Accelerates Tumorigenicity of Myeloma Cells J. Virol., September 15, 2000; 74(18): 8226 - 8233. [Abstract] [Full Text] |
||||
![]() |
T. J. Wrona, M. Lozano, A. A. Binhazim, and J. P. Dudley Mutational and Functional Analysis of the C-Terminal Region of the C3H Mouse Mammary Tumor Virus Superantigen J. Virol., June 1, 1998; 72(6): 4746 - 4755. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |